Denis Chem Lab Ltd (BSE: 537536) is an Ahmedabad, Gujarat-based company in the Pharmaceutical Contract Manufacturing Services industry. With a market capitalisation of ₹87 Cr, it ranks #3,349 by market cap among the 6,197 Indian listed companies on FinBizNet, and #18 of 26 in Pharmaceutical Contract Manufacturing Services. At ₹63.00 (as of 16 Nov 2026), the share price is 31.5% below its 52-week high of ₹92.00 and 15.6% above its 52-week low of ₹54.50. The share price is down 32.4% over one year and down 12.2% over three months.
| Current Price | ₹63.00 |
|---|---|
| Market Cap | ₹87 Cr |
| BSE Code | 537536 |
| Sector | Health Care > Pharmaceuticals, Biotechnology and Life Sciences > Pharmaceuticals |
| Sub-Industry | Pharmaceuticals > Pharmaceutical Contract Manufacturing Services |
| 52-Week Range | ₹54.50 – ₹92.00 |
| 1-Year Price Change | -32.4% |
| 3-Month Price Change | -12.2% |
| Beta (1Y) | 0.9 |
| Dividend Yield | 3.97% |
| Headquarters | Ahmedabad, Gujarat |
| Website | denischemlab.com |
| Revenue | ₹44 Cr |
|---|---|
| Net Profit | ₹2 Cr |
| Net Margin | 4.7% |
| EPS (Basic) | ₹1.47 |
| Basis | standalone |
Figures in ₹ crore, parsed from the company's exchange filing (XBRL).
Denis Chem Lab Ltd reported revenue of ₹44 Cr in Q1 FY27, up 1.7% from ₹43 Cr in Q1 FY26 and down 5.9% from ₹47 Cr in Q4 FY26. It posted a net profit of ₹2 Cr for the quarter, against a net profit of ₹2 Cr in Q1 FY26 (down 17.3%). Across the 6 quarters from Q4 FY25 to Q1 FY27, quarterly revenue ranged from ₹41 Cr (Q4 FY25) to ₹47 Cr (Q4 FY26). The company was profitable in each of these 6 quarters.
| Quarter | Revenue | Net Profit | Net Margin |
|---|---|---|---|
| Q1 FY27 | ₹44 Cr | ₹2 Cr | 4.7% |
| Q4 FY26 | ₹47 Cr | ₹0 Cr | 0.9% |
| Q3 FY26 | ₹46 Cr | ₹3 Cr | 7.3% |
| Q2 FY26 | ₹46 Cr | ₹2 Cr | 4.8% |
| Q1 FY26 | ₹43 Cr | ₹2 Cr | 5.7% |
| Q4 FY25 | ₹41 Cr | ₹1 Cr | 1.7% |
Standalone figures (₹ crore, XBRL filings).
Delivery averaged 86.3% of traded volume across 15 BSE sessions (21 Oct 2026 – 13 Nov 2026).
Denis Chem Lab Limited, a pharmaceutical company, engages in the manufacturing and marketing of sterile intravenous injectable products for human and veterinary use in India. The company’s products include antibiotic injections, diuretic injections, parenteral amino acid injections, plasma volume expanders, anti-anaerobic injections, anti-pyretic injections, irrigation and dialysis solutions, etc. It also provides contract manufacturing services for third parties, as well as manufactures and sells transfusion solutions in bottles. The company serves government and semi-government institutions, hospitals and nursing homes, aided agencies, and defense sector. It also exports its products to Sri Lanka, Vietnam, Cambodia, Somalia, Nepal, Ivory Coast, etc. The company was incorporated in 1980 and is based in Ahmedabad, India.
1. 0-0
| Company | Market Cap | P/E | ROE | Latest Qtr Revenue | 1Y Change |
|---|---|---|---|---|---|
| Torrent Pharma Ltd. | ₹1,79,494 Cr | 73.6 | 16.98% | ₹4,979 Cr | +30.4% |
| Aether Industries Limited | ₹21,710 Cr | 101.8 | 9.81% | ₹347 Cr | +127.8% |
| Alivus Life Sciences Ltd | ₹17,862 Cr | 31.5 | 18.36% | ₹682 Cr | +64.0% |
| Aarti Pharmalabs Ltd | ₹8,374 Cr | 52.5 | 8.49% | ₹610 Cr | +15.4% |
| Solara Active Pharma Sciences Limited | ₹3,225 Cr | n/m | -0.63% | ₹417 Cr | +22.1% |
| Sai Parenteral's Limited | ₹2,235 Cr | 115.8 | 2.88% | ₹195 Cr | — |
| KRM Ayurveda Limited | ₹521 Cr | 25.9 | 17.54% | ₹32 Cr | — |
| Trident Lifeline Limited | ₹511 Cr | 26 | — | — | +37.6% |
| Denis Chem Lab Ltd | ₹87 Cr | — | — | ₹44 Cr | -32.4% |
Listed by market capitalisation. Ratios are shown for context only.
Denis Chem Lab Ltd is trading at ₹63.00, with a market capitalisation of ₹87 Cr.
Denis Chem Lab Ltd operates in the Health Care > Pharmaceuticals, Biotechnology and Life Sciences > Pharmaceuticals space (Pharmaceuticals > Pharmaceutical Contract Manufacturing Services).
Denis Chem Lab Ltd is listed on the BSE under the scrip code 537536.
Denis Chem Lab Ltd's share price is down 32.4% over one year and down 12.2% over three months. Its 52-week range is ₹54.50 to ₹92.00.
In Q1 FY27, Denis Chem Lab Ltd reported revenue of ₹44 Cr and net profit of ₹2 Cr, with basic EPS of ₹1.47 (standalone, parsed from the company's exchange filing).
Denis Chem Lab Ltd reported revenue of ₹44 Cr in Q1 FY27, up 1.7% from ₹43 Cr in Q1 FY26 and down 5.9% from ₹47 Cr in Q4 FY26.
Data as of 16 Nov 2026. Descriptive market data only — not investment advice.